-- Phase III Studies Show Statistically Significant Decrease in Number of Headache Days -- IRVINE, Calif., Sep 11, 2008 (BUSINESS WIRE) -- Allergan, Inc. (NYSE: AGN) today announced that it has completed a top-line analysis of its two Phase III... ...